Formosa Laboratories, Inc. (TPE:4746)

Taiwan · Delayed Price · Currency is TWD

50.50

-2.20 (-4.17%)

At close: Mar 9, 2026

-29.07% (1Y)

Market Cap	6.07B
Revenue (ttm)	4.90B
Net Income (ttm)	240.77M
Shares Out	120.26M
EPS (ttm)	1.99
PE Ratio	25.37
Forward PE	n/a
Dividend	3.00 (5.69%)
Ex-Dividend Date	Aug 21, 2025

Volume	1,126,395
Average Volume	878,381
Open	51.30
Previous Close	52.70
Day's Range	50.00 - 51.50
52-Week Range	49.50 - 74.40
Beta	0.77
RSI	31.43
Earnings Date	Mar 17, 2026

About Formosa Laboratories

Formosa Laboratories, Inc., together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. The company offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, antibiot... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1985

Employees 280

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 4746

Full Company Profile

Financial Performance

In 2024, Formosa Laboratories's revenue was 4.73 billion, an increase of 8.50% compared to the previous year's 4.36 billion. Earnings were 157.27 million, an increase of 24.58%.

Financial Statements

News

There is no news available yet.